Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
The American Journal of the Medical Sciences|January 12, 2022
Perception, Prevalence, and Prediction of Severe Infection and Post-acute Sequelae of COVID-19Dacre R T Knight, Bala Munipalli, Ilana I Logvinov, et al.Hereditary Cancer in Clinical Practice|July 25, 2017
Late onset asymptomatic pancreatic neuroendocrine tumor - A case report on the phenotypic expansion for MEN1Charu Kaiwar, Sarah K Macklin, Jennifer M Gass, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 24, 2015
Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy: a 5-year follow-upNeil Majithia, Pamela J Atherton, Jacqueline M Lafky, et al.BMC Medical Genetics|August 19, 2020
Case report expanding the germline AXIN2- related phenotype to include olfactory neuroblastoma and gastric adenomaSarah K Macklin-Mantia, Stephanie L Hines, Kaisorn L Chaichana, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancerStephanie L Hines, Betty Anne Mincey, Jeff A Sloan, et al.Cancer|May 2, 2015
5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trialNina D Wagner-Johnston, Jeff A Sloan, Heshan Liu, et al.Case Reports in Genetics|February 13, 2020
Characterization of a Pathogenic Variant in the ABCD1 Gene Through Protein Molecular ModelingJohn E Richter, Charitha Vadlamudi, Sarah K Macklin, et al.Breast (Edinburgh, Scotland)|January 19, 2010
Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapyStephanie L Hines, Jeff A Sloan, Pamela J Atherton, et al.Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|September 8, 2020
Intensive Multicomponent Fibromyalgia Treatment: A Translational Study to Evaluate Effectiveness in Routine Care DeliveryBarbara K Bruce, Madeleine E Allman, Fernando A Rivera, et al.Breast Cancer Research and Treatment|February 14, 2009
Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CCStephanie L Hines, Betty Mincey, Todor Dentchev, et al.Pageof 3